Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Medical Physics|April 14, 2025
Patient-specific modeling of radiation-induced lymphopenia for head and neck cancerJiaxin Li, Rahul Mali, Gregory N Gan, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 20, 2023
Assessing the Risk of Adjuvant Radiotherapy Initiation Delays With Social Support SurveysBryan Renslo, Tuleen Sawaf, Celina G Virgen, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 2, 2022
Prognostic Implications of Skin Invasion in Locally Advanced Oral Cavity Squamous Cell CarcinomaJennifer H Diebolt, Katherine M Yu, Stephanie Wood, et al.
Cancer Research|October 10, 2014
Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancersGregory N Gan, Justin Eagles, Stephen B Keysar, et al.
Oncogene|August 17, 2019
MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinomaKiersten L Berggren, Sebastian Restrepo Cruz, Michael D Hixon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 25, 2009
A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study)N Venketasubramanian, C L H Chen, R N Gan, et al.
Singapore Medical Journal|September 1, 2011
Brain attack: needing resuscitationN Venketasubramanian, B P L Chan, H M Chang, et al.
The Lancet. Oncology|May 31, 2025
Nutrition in head and neck cancer care: a roadmap and call for researchXin Chen, Brooke Beilman, Heather D Gibbs, et al.
Oral Oncology Reports|May 13, 2026
Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapyD Morgan, E Schueddig, A Segura, et al.
Plos Pathogens|January 22, 2021
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumorsAdrian J Luna, Rosa T Sterk, Anastacia M Griego-Fisher, et al.
Pageof 11